FREE CASE EVALUATION: 1-800-632-1404
Tens of thousands of women receive a transvaginal mesh (TVM) device each and every year from numerous suppliers: American Medical Systems, Bard, Boston Scientific, Ethicon,Gynecare, and Johnson & Johnson. Thousands of women have been injured through no fault of their own, including vaginal erosion, pain, urinary problems, bleeding, infection and more. Our attorneys are representing women in all fifty states and Canada who have been injured. For a free case evaluation, call 1-800-632-1404.
We are honored to have two women on staff ready and willing to discuss the facts of your case with you as often as needed.
Multi-District Litigation Pushing Ahead
Judge Joseph R. Goodwin who was already in charge of a multidistrict litigation involving defective transvaginal mesh has been assigned three more multidistrict litigation involving transvaginal meshes manufactured by Ethicon Inc, Boston Scientific Corp and American Medical Systems Inc.
A multidistrict litigation is different from a class action. In a class action all lawsuits are heard as one but in a multidistrict litigation, the cases are heard together but each has its own trial. A multidistrict litigation status provides the plaintiffs added leverage especially in lawsuits against large corporations. The plaintiff attorneys working in a multidistrict litigation can pool their resources during the discovery period. In a traditional lawsuit on the other hand, the time and resources available are limited.
Transvaginal mesh is used to treat urinary incontinence. However there have been reports of recurrence of the incontinence. Urinary incontinence is the inappropriate and involuntary passage of urine. Its exact prevalence is difficult to establish because it can occur in varying degrees and the patient may deny having the problem. Urinary incontinence is an issue of quality of life that should be neither ignored nor denied.
Urinary incontinence undermines the patient’s self-confidence, worsens her general condition, and disrupts her precarious equilibrium with her environment. It is remarkable how often the patient’s relatives try to conceal the problem. When questioned, they may deny that their relative is incontinent until the situation becomes intolerable, in which case often little can be done apart from seeking institutional care. This situation is unfortunate because, even in late cases, a reversible cause for urinary incontinence sometimes can be found and treated. A bout of urinary incontinence, even an isolated one, can be so humiliating for the patient that it completely undermines self confidence and significantly accelerates the rate of decline.
Urinary incontinence is one of the major factors underlying the development of skin irritation and breakdown. Prolonged contact with moisture and urine lessens the skin’s ability to remain intact. Skin breakdown can lead to increased length of hospital stays, increased cost of care, increased risk for infection, and can be extremely painful for the patient.
Our team of attorneys is reviewing case evaluations for women across the country who have received TVM and TVT products from manufactures such as C.R. Bard, Avaulta, Boston Scientific, and Johnson & Johnson’s Ethicon.
If you need help from a transvaginal mesh device injury, call us today for help.
The Problem
In 2008, the FDA first released concerns about the safety of transvaginal placement of mesh. From 2008 to 2010, the FDA received three to five times as many adverse reports associated with mesh used for pelvic organ prolapse repair than what agency received from 2005 to 2007 (nearly 1,000 reports of adverse events were received from 2005-2007).
Many of these patients complain because of erosion or contraction of the mesh material (which has been described as being of a similar material as Rubbermaid storage containers). The erosion leads to bleeding, severe pelvic pain, painful (or impossible) sexual performance and a recurrence of urinary problems.
In July 2011, the Food and Drug Administration (FDA) issued an update related to what it called ‘serious complications’ related to the use of vaginal mesh for treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). It is now known that complications linked to transvaginal placement of surgical mesh in SUI and POP patients are not rare and can require multiple surgeries to correct problems related to the use of surgical mesh. In fact, the FDA now says that additional surgeries may actually not be able to repair damage caused by implantation of the mesh.
In other words, the side effects of the mesh placement may be permanent. These complications from transvaginal placement of surgical mesh include:
- -Erosion of the implanted mesh
- -Infection and/or bleeding
- -Pain, including pain during sexual intercourse
- -Problems with organs near the implantation site
Helping You
You may have experienced mesh erosion, bleeding, urinary infections, vaginal scarring, pain during sexual intercourse, failure to conduct sexual intercourse and more. A physician may have tried to remove the mesh and been unable to do so. You may be in excruciating pain, and need help. We are offering free case evaluations to the general public across the United States and Canada. Manufacturers we consider include American Medical Systems, Bard, Boston Scientific, Ethicon,Gynecare, and Johnson & Johnson.
If you received a transvaginal mesh / sling and have been injured, you may be entitled to monetary compensation. Problems include pain, inability to have intercourse,bleeding, mesh growth into the body, mesh erosion, and more. Problems could be irreversible. Please fill out the form to the right or call us so that we can provide you with forms to evaluate your potential case immediately.
We are accepting case evaluations nationwide and in Canada, as well. Please do not hesitate or delay in contacating TVM / TVT Sling and transvaginal mesh attorneys :
CALL: 1-800-632-1404
EMAIL: clicking here
FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.